Treatment of hepatitis C virus infection with interferon and small molecule direct antivirals: viral kinetics and modeling
about
Quantification of viral infection dynamics in animal experimentsMathematical model of viral kinetics in vitro estimates the number of E2-CD81 complexes necessary for hepatitis C virus entryNovel small-molecule inhibitors of hepatitis C virus entry block viral spread and promote viral clearance in cell cultureRibavirin-induced anemia in hepatitis C virus patients undergoing combination therapy.Viral kinetics suggests a reconciliation of the disparate observations of the modulation of claudin-1 expression on cells exposed to hepatitis C virus.Analysis of hepatitis C virus decline during treatment with the protease inhibitor danoprevir using a multiscale modelInhibitory effect of kaolin minerals compound against hepatitis C virus in Huh-7 cell linesHepatitis C Viral Kinetics in the Era of Direct Acting Antiviral Agents and IL28B.Hepatitis C viral kinetics: the past, present, and future.Pharmacokinetics, safety, and tolerability of GS-9851, a nucleotide analog polymerase inhibitor for hepatitis C virus, following single ascending doses in healthy subjects.Pharmacokinetics, pharmacodynamics, and tolerability of GS-9851, a nucleotide analog polymerase inhibitor, following multiple ascending doses in patients with chronic hepatitis C infection.Early dynamics of viremia in patients with genotype 1b chronic hepatitis C: Peg-IFNalpha2a shows earlier viral decline than peg-IFNalpha2b in combination therapy with ribavirin.Mathematical analysis of multiscale models for hepatitis C virus dynamics under therapy with direct-acting antiviral agents.Future treatment of chronic hepatitis C with direct acting antivirals: is resistance important?The Role of IFN-alpha in Experimental and Clinical Uveitis.Treatment of experienced and naïve patients with hepatitis C: focus on telaprevir.The impact of hepatitis A virus infection on hepatitis C virus infection: a competitive exclusion hypothesis.Association of hepatitis C virus NS5B variants with resistance to new antiviral drugs among untreated patients.The Role of Infected Cell Proliferation in the Clearance of Acute HBV Infection in Humans.Immunopathogenesis and Virus-Host Interactions of Enterovirus 71 in Patients with Hand, Foot and Mouth Disease.A New Model for the Dynamics of Hepatitis C Infection: Derivation, Analysis and Implications.
P2860
Q26824804-1F2D8F6E-23CC-46D7-9B8A-E8B7CC7B8D27Q28478310-D5AE6AFB-B990-415C-8D1B-75D764076A56Q28482494-FEB3000B-54A2-4814-98EE-9F515632E196Q33815550-174BCDA9-94C4-4C52-AEF0-B0A6C021C905Q34251341-CB196047-9A5C-4B5E-B595-CF88842BA704Q34334375-5756B2C0-4A24-4964-9C18-9ABAEEF97B10Q35151302-6F0C58F3-F44F-40A2-86A1-98527FFF0AD4Q35610571-F5F0AC8B-709E-44EE-ACD2-45EAF82B4EB6Q36645517-0D77B4C8-FA57-4157-B12F-544058BE4EB5Q36667039-7FA98F0B-21C1-496C-BC73-F46EA5510FFCQ36667165-6779B9AB-7D08-4A52-9D07-5E11D2ABB259Q36771385-6EF051B1-F2EF-4DBD-94C7-E08EA6258835Q37138516-181C1153-357B-4E73-BC15-78F5CEB3E25EQ37972767-D4FBE38C-84A4-4098-B64E-09960F0884E6Q38856516-5453EE0B-7F4D-4911-9237-861662161466Q39526702-25F171A1-947E-4B01-B764-CC73E73A28BCQ42986690-91438095-B87F-4830-8FB6-31DEC95E6BD3Q43046674-297F39FB-7DF6-4002-99D1-FA3F14471A91Q47131005-38F120F1-DE9B-499E-B87F-26BF33AF16A4Q47145137-088A09DA-22FE-48A3-86ED-11DC9024D75EQ52589911-7E2D545B-ABA1-4F33-8A22-C2E23148C623
P2860
Treatment of hepatitis C virus infection with interferon and small molecule direct antivirals: viral kinetics and modeling
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Treatment of hepatitis C virus ...... s: viral kinetics and modeling
@ast
Treatment of hepatitis C virus ...... s: viral kinetics and modeling
@en
type
label
Treatment of hepatitis C virus ...... s: viral kinetics and modeling
@ast
Treatment of hepatitis C virus ...... s: viral kinetics and modeling
@en
prefLabel
Treatment of hepatitis C virus ...... s: viral kinetics and modeling
@ast
Treatment of hepatitis C virus ...... s: viral kinetics and modeling
@en
P2860
P1476
Treatment of hepatitis C virus ...... s: viral kinetics and modeling
@en
P2093
Libin Rong
P2860
P304
P356
10.1615/CRITREVIMMUNOL.V30.I2.30
P577
2010-01-01T00:00:00Z